PET117 inhibitors are a specialized class of chemical compounds that target the PET117 protein, which plays a crucial role in mitochondrial complex IV assembly. Mitochondrial complex IV, also known as cytochrome c oxidase, is a key component of the electron transport chain, essential for cellular respiration and energy production. PET117 is a mitochondrial assembly factor, ensuring the proper formation and function of complex IV. By inhibiting PET117, researchers can study the specific mechanisms through which this protein influences mitochondrial function and the broader implications for cellular bioenergetics. These inhibitors serve as valuable tools in biochemical and biophysical research, allowing scientists to dissect the pathways and interactions involved in mitochondrial assembly and function.
The development and characterization of PET117 inhibitors involve rigorous screening processes to identify compounds with high specificity and efficacy. Structural biology techniques, such as X-ray crystallography and NMR spectroscopy, are employed to elucidate the binding interactions between PET117 and its inhibitors. Computational modeling and molecular dynamics simulations further aid in understanding the conformational changes and stability of the inhibitor-protein complexes. Moreover, these inhibitors are crucial in studying the perturbations in mitochondrial dynamics and metabolic processes, providing insights into the role of PET117 in cellular homeostasis. Advanced analytical methods, including mass spectrometry and high-throughput screening, facilitate the identification and optimization of potent PET117 inhibitors, ensuring their relevance and effectiveness in research applications.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
A multi-kinase inhibitor, could disrupt cell signaling pathways that might intersect with Pet117's role in cellular processes. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
CDK4/6 inhibitor, might impact cell cycle regulation, which could be related to Pet117's function in cell proliferation. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
BCR-ABL tyrosine kinase inhibitor, may influence cell proliferation and survival pathways, intersecting with Pet117's activities. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $412.00 | 32 | |
Dual EGFR and HER2 inhibitor, could modify signaling pathways potentially linked to Pet117's role in cell growth and differentiation. | ||||||
Vemurafenib | 918504-65-1 | sc-364643 sc-364643A | 10 mg 50 mg | $115.00 $415.00 | 11 | |
BRAF inhibitor, might impact cell growth and apoptosis pathways, potentially related to Pet117's function. | ||||||
Cobimetinib | 934660-93-2 | sc-507421 | 5 mg | $270.00 | ||
MEK inhibitor, could influence cell signaling pathways that intersect with Pet117's potential roles. | ||||||
Erlotinib Hydrochloride | 183319-69-9 | sc-202154 sc-202154A | 10 mg 25 mg | $74.00 $119.00 | 33 | |
EGFR inhibitor, may modify pathways related to cell proliferation and survival, potentially intersecting with Pet117's role. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $112.00 $163.00 $928.00 | 19 | |
MEK inhibitor, might affect cell signaling pathways, potentially related to Pet117's activities in cellular processes. | ||||||
Ribociclib | 1211441-98-3 | sc-507367 | 10 mg | $450.00 | ||
CDK4/6 inhibitor, could modify cell cycle regulation, potentially intersecting with Pet117's function in cell proliferation. | ||||||